Wall Street brokerages predict that Omeros Co. (NASDAQ:OMER) will announce $31.38 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Om
Omeros (NASDAQ:OMER) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Tuesday, BidAskClub reports. A number of othe
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its fourth quarter and year-end 2019 financial results for the period ended December 31, 2019, o
Shares of Omeros Co. (NASDAQ:OMER) have earned an average recommendation of “Hold” from the eight analysts that are presently covering the company, Marketbeat.com reports. Two investment analysts
In 1994 Greg Demopulos was appointed CEO of Omeros Corporation (NASDAQ:OMER). First, this article will compare CEO...
Gregory Demopulos became the CEO of Omeros Corporation (NASDAQ:OMER) in 1994. This report will, first, examine the CEO...
Omeros Corporation (NASDAQ: OMER) today announced the appointment of Kurt Zumwalt, former global treasurer of Amazon.com, Inc., to Omeros’ Board of Directors. He will also serve in a consulting role

Omeros: 2 Major Catalysts On The Horizon

07:16am, Monday, 10'th Feb 2020
Omeros Corporation has had positive news regarding its late-stage candidate OMS721 counterbalanced by concerns that its product Omidria may lose its separate re
Equities research analysts expect Omeros Co. (NASDAQ:OMER) to report ($0.33) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for O

Most Heavily Shorted Stocks - February 2020

06:30pm, Thursday, 06'th Feb 2020
This article presents a list of stocks with the highest short interest as a percentage of shares outstanding. The most heavily shorted stocks here are generally
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscien

Omeros (NASDAQ:OMER) Downgraded by BidaskClub

08:52am, Tuesday, 04'th Feb 2020
Omeros (NASDAQ:OMER) was downgraded by equities research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report issued on Tuesday, BidAskClub reports. Several other
Pomerantz LLP is investigating claims on behalf of investors of Omeros Corporation (“Omeros” or the “Company”) (OMER). Such investors are advised to contact Robert S. Willoughby at rswillough

Stocks That Hit 52-Week Lows On Monday

04:53pm, Monday, 03'rd Feb 2020
Monday's morning session saw 187 companies set new 52-week lows. Interesting Highlights: Xperi (NASDAQ: XPER) was the biggest company on a market cap basis to set a...
The new February selections for both Positive and Negative Forensic Value stocks released in alternating months with the Piotroski-Graham Value selections. 11 P
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE